Unit dosage forms for the treatment of herpes simplex

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6231889
SERIAL NO

09396019

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The components of this invention are chosen because of their complementarity for the prevention or treatment of diseases caused by the herpes simplex virus. L-Lysine favorably increases the physiologic immunomodulation necessary for defense against this virus. Zinc improves and maintains a normal immune response. 2-Deoxy-2-D-glucose and heparin sodium alter the surface interaction between the herpes virus and the cell, preventing fusion and infectivity. N-Acetyl-L-cysteine increases glutathione levels thereby creating a thiol redox barrier to the virus at the cell membrane. Quercetin reduces intracellular replication of the herpes virus and viral infectivity. Ascorbate, in concert with copper and D-.alpha.-tocopherol, provides an antioxidant defense against the herpes virus, which tends to lose latency during period of oxidative, free radical excess. Selenium and quercetin also participate in reducing various oxidative stresses. Together the components of this invention provide the potential for improved resistance to, improved recovery from, and a decreased frequency of recurrence of herpes simplex virus infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CHRONORX, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pearson, Don C Lakewood, WA 20 468
Richardson, Kenneth T Anchorage, AK 21 481

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation